HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

3- hydroxy- 2,2- dimethyl- N- (4(((5- (dimethylamino)- 1- naphthyl)sulfonyl)amino)phenyl)propanamide

structure in first source

Also Known As:

BAY 38-4766

Networked: 2 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Experts

1.	Bernstein, David I: 1 article (01/2005)
2.	Bravo, Fernando: 1 article (01/2005)
3.	Creasy, Blaine: 1 article (01/2005)
4.	Hallenberger, Sabine: 1 article (01/2005)
5.	Henninger, Kristin: 1 article (01/2005)
6.	McGregor, Alistair: 1 article (01/2005)
7.	McVoy, Michael A: 1 article (01/2005)
8.	Schleiss, Mark R: 1 article (01/2005)
9.	Stroup, Greg: 1 article (01/2005)
10.	Bender, W: 1 article (03/2001)

Related Diseases

1.	Viremia 01/01/2005 - "Treatment with BAY 38-4766 reduced both viremia and DNAemia, as determined by a real-time PCR assay, following GPCMV infection of cyclophosphamide-immunosuppressed strain 2 guinea pigs (p<0.05, Mann-Whitney test). "
2.	Infections 01/01/2005 - "Treatment with BAY 38-4766 reduced both viremia and DNAemia, as determined by a real-time PCR assay, following GPCMV infection of cyclophosphamide-immunosuppressed strain 2 guinea pigs (p<0.05, Mann-Whitney test). "
3.	Body Weight (Weight, Body) 03/01/2001 - "Per os administration of BAY 38-4766 at dosages > or = 10 mg/kg body weight led to antiviral effects that were comparable to ganciclovir 9-(1,3-dihydroxy-2-propoxymethyl)-guanine (Cymevene) as measured by survival and levels of viral DNA in organs of infected mice. "

Related Drugs and Biologics

1.	Ganciclovir (Cytovene)
2.	Viral DNA
3.	Cyclophosphamide (Cytoxan)
4.	Antiviral Agents (Antivirals)